Infectious Disease Doctors in Little Rock, AR Accepting Medicare

17 Infectious Disease doctors found. Showing 1 - 17

Priyenka Thapa, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Saint Vincent Cir Ste 160, Little Rock, AR 72205 Phone: 501-661-0037    Fax: 501-661-0038

Dr. Mitchell B Jenkins, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St # 547, Little Rock, AR 72205 Phone: 501-603-1616    Fax: 501-603-1480

Joseph G Wyble, M.D. Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 10001 Lile Dr, Little Rock, AR 72205 Phone: 501-227-8000    Fax: 501-320-1620

Dr. Brandon Walser, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Saint Vincent Cir, Suite 160, Little Rock, AR 72205 Phone: 501-661-0037    Fax: 501-661-0038

Monica Grazziutti, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St, Uams #783, Little Rock, AR 72205 Phone: 501-686-8000    Fax: 501-686-5609

Jeremy Bariola, Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St, Slot 639, Little Rock, AR 72205 Phone: 501-686-5585

Dr. Naveen Patil, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4815 W Markham St, Little Rock, AR 72205 Phone: 501-661-2152    Fax: 501-661-2226

Mrs. Katherine Mclean Ferren, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Saint Vincent Cir Ste 160, Little Rock, AR 72205 Phone: 501-661-0067    Fax: 501-661-0038

Dr. Keyur Vyas, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000

Robert Bradsher, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000

John E Dietrich, M.D. Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 1 Saint Vincent Cir, Suite 160, Little Rock, AR 72205 Phone: 501-661-0037    Fax: 501-661-0038

Dwight A Lindley, M.D, Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Saint Vincent Cir, Suite 160, Little Rock, AR 72205 Phone: 501-611-0037    Fax: 501-661-0038

Nathaniel H Smith, M.D. Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 4815 W. Markham St.,, Slot 52, Little Rock, AR 72205 Phone: 501-661-2919    Fax: 501-661-2240

Michael Saccente, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000

Thomas Phillip Monson, MD Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-5585

Dr. Ryan Keith Dare, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St, Slot 639, Little Rock, AR 72205 Phone: 501-686-5335

Dr. Rebecca Edge Martin, M.D. Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 4300 W 7th St, Little Rock, AR 72205 Phone: 501-257-5778

News Archive

Strawberries for prevention of esophageal cancer: Study

According to a preliminary study released Wednesday, strawberries have the potential to prevent esophageal cancer. Researchers, led by Ohio State University have shown that freeze-dried strawberries slowed the growth of dysplastic, or precancerous, lesions in about 30 people who consumed the fruit for six months. Study's lead researcher, Tong Chen, an assistant professor in the oncology division of Ohio State University, presented the study at the American Association for Cancer Research's annual meeting.

NovaBay Pharmaceuticals to deliver new data on Aganocide compounds at ICAAC Conference

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, will deliver four poster presentations on its compounds at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).

FDA approves CBD oral solution for treatment of seizures related to tuberous sclerosis complex

Today, the U.S. Food and Drug Administration approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with tuberous sclerosis complex (TSC) in patients one year of age and older.

Immunotherapeutic antibody therapy to kill cancer has now progressed to patient testing

Developed by researchers at the University of Turku in Finland, an immunotherapeutic antibody therapy re-educates macrophages to activate passivated cytotoxic T cells to kill cancer. The antibody therapy prevented the growth of tumors in several mouse models.

Read more Medical News

› Verified 7 days ago